US Drug Recall Register
Class II · Moderate risk Terminated Initiated Nov 7, 2014 (12 years ago)

Sodium Tetradecyl SO4 0.3% Inj.

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

What was recalled

Sodium Tetradecyl SO4 0.3% Inj., 30 Ml vials, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS --- NDC 88888-6427-90

Recalling firm
Perry Drug Inc.
NDC code
88888-6427-90
Origin
KS, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0275-2015

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Tetradecyl recalls

See all
Class II · Moderate risk Completed

Sodium Tetradecyl Sulfate 5% MDV Injection

Reason Lack of assurance of sterility.

Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0102-05 D-0908-2022
Class II · Moderate risk Completed

Sodium Tetradecyl Sulfate 0.3% Injection

Reason Lack of assurance of sterility.

Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0121-30 D-0906-2022
Class II · Moderate risk Terminated

Sodium Tetradecyl Sulfate

Reason Lack of Assurance of Sterility; all sterile human compounded drugs within expiry

JD & SN Inc., dba Moses Lake Professional Pharmacy D-0123-2016
Class II · Moderate risk Terminated

Sodium Tetradecyl Sulfate 5% Injectable

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1635-2015